Logo image of SYK

STRYKER CORP (SYK) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:SYK - US8636671013 - Common Stock

371.18 USD
-1.11 (-0.3%)
Last: 11/28/2025, 8:02:22 PM
371.18 USD
0 (0%)
After Hours: 11/28/2025, 8:02:22 PM

SYK Key Statistics, Chart & Performance

Key Statistics
Market Cap141.95B
Revenue(TTM)24.38B
Net Income(TTM)2.94B
Shares382.42M
Float361.55M
52 Week High406.19
52 Week Low329.16
Yearly Dividend3.2
Dividend Yield0.9%
EPS(TTM)13.17
PE28.18
Fwd PE24.76
Earnings (Next)01-26 2026-01-26/amc
IPO1980-03-17
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


SYK short term performance overview.The bars show the price performance of SYK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4

SYK long term performance overview.The bars show the price performance of SYK in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40

The current stock price of SYK is 371.18 USD. In the past month the price increased by 0.6%. In the past year, price decreased by -5.35%.

STRYKER CORP / SYK Daily stock chart

SYK Latest News, Press Relases and Analysis

SYK Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.83 224.14B
ISRG INTUITIVE SURGICAL INC 66.61 203.30B
BSX BOSTON SCIENTIFIC CORP 34.43 150.59B
IDXX IDEXX LABORATORIES INC 59.7 60.12B
BDX BECTON DICKINSON AND CO 13.45 55.61B
EW EDWARDS LIFESCIENCES CORP 33.72 50.29B
RMD RESMED INC 25.84 37.34B
GEHC GE HEALTHCARE TECHNOLOGY 17.43 36.44B
DXCM DEXCOM INC 34.12 24.75B
PODD INSULET CORP 71.6 23.02B
ZBH ZIMMER BIOMET HOLDINGS INC 12.05 19.33B
HOLX HOLOGIC INC 17.56 16.71B

About SYK

Company Profile

SYK logo image Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 53,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

Company Info

STRYKER CORP

1941 Stryker Way

Portage MICHIGAN 49002 US

CEO: Kevin A. Lobo

Employees: 53000

SYK Company Website

SYK Investor Relations

Phone: 12693852600

STRYKER CORP / SYK FAQ

What does STRYKER CORP do?

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 53,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.


What is the current price of SYK stock?

The current stock price of SYK is 371.18 USD. The price decreased by -0.3% in the last trading session.


What is the dividend status of STRYKER CORP?

STRYKER CORP (SYK) has a dividend yield of 0.9%. The yearly dividend amount is currently 3.2.


How is the ChartMill rating for STRYKER CORP?

SYK has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Can you provide the number of employees for STRYKER CORP?

STRYKER CORP (SYK) currently has 53000 employees.


What is the market capitalization of SYK stock?

STRYKER CORP (SYK) has a market capitalization of 141.95B USD. This makes SYK a Large Cap stock.


Can you provide the ownership details for SYK stock?

You can find the ownership structure of STRYKER CORP (SYK) on the Ownership tab.


SYK Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to SYK. When comparing the yearly performance of all stocks, SYK is a bad performer in the overall market: 68.74% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SYK Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to SYK. While SYK belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SYK Financial Highlights

Over the last trailing twelve months SYK reported a non-GAAP Earnings per Share(EPS) of 13.17. The EPS increased by 13.14% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.07%
ROA 6.25%
ROE 13.51%
Debt/Equity 0.68
Chartmill High Growth Momentum
EPS Q2Q%11.15%
Sales Q2Q%10.25%
EPS 1Y (TTM)13.14%
Revenue 1Y (TTM)10.95%

SYK Forecast & Estimates

37 analysts have analysed SYK and the average price target is 438.19 USD. This implies a price increase of 18.05% is expected in the next year compared to the current price of 371.18.

For the next year, analysts expect an EPS growth of 11.17% and a revenue growth 10.86% for SYK


Analysts
Analysts80
Price Target438.19 (18.05%)
EPS Next Y11.17%
Revenue Next Year10.86%

SYK Ownership

Ownership
Inst Owners81.52%
Ins Owners0.11%
Short Float %1.17%
Short Ratio2.65